Association of Hydrogen Sulfide with Femoral Bone Mineral Density in Osteoporosis Patients: A Preliminary Study

14 March 2021 : Clinical Research

Yan-Ming Hao^1ACDE, Da-Wei He^2BD, Yan Gao^1BCF, Ling-Na Fang^3E, Pan-Pan Zhang^4BC, Ke Lu^1BC, Rong-Zhu Lu^2B, Chong Li^5AEFG*

DOI: 10.12659/MSM.929389

Med Sci Monit 2021; 27:e929389

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 1 Clinical characteristics of the study participants.

Variables	Control (n=75)	Osteopenia (n=16)	Osteoporosis (n=9)	P value
Age	50.2±1.1	55.6±1.5^*	79.2±3.1^*	0.045
Male/Female	58/17	10/6	2/7	0.041
BMD (lumbar spine)	1.23±0.11	1.01±0.12^*	0.76±0.04^*	0.012
BMD (femoral neck)	0.97±0.08	0.78±0.06^*	0.54±0.02^*	0.011
T value (lumbar spine)	0.66±0.12	−1.59±0.10^*	−2.6±0.32^*	0.008
T value (femoral neck)	0.64±0.12	−1.44±0.11^*	−3.17±0.18^*	0.005
Values are expressed as mean±SD. ^* P ^# P The gender in three groups was analyzed using χ test, other variables in three groups was analyzed one-way analysis of variance.

Back to the Article